Literature DB >> 24551650

Study of bone mineral density in patients with ankylosing spondylitis.

Hatinder Jeet Singh1, Kaur Nimarpreet2, Sibadatta Das3, Ashok Kumar4, Shesh Prakash5.   

Abstract

INTRODUCTION: Ankylosing spondylitis (AS) is an inflammatory rheumatic disease characterized by spine and sacroiliac joint involvement that mainly affects young male subjects. Bone Mineral Density (BMD) loss occurs in AS disease course. Bone loss in AS appears to be multifactorial and perhaps involves different mechanisms at different stages of disease. The disease typically affects young males and is associated with progressive functional impairment, increased work disability and decreased quality of life. Osteoporosis is frequent in AS and there is a close association of bone mineral density, bone metabolism and inflammatory activity. Osteoporosis is frequently associated with AS and BMD decreased predominantly in patients with active disease. AIMS &
OBJECTIVES: The aim of the present study was to study bone mineral density in cases of Ankylosing Spondylitis (AS) in comparison to age and sex matched controls.
MATERIAL AND METHODS: The present study was conducted on 100 established cases of AS based on modified New York criteria and 150 controls healthy, age, race, socio-economic matched controls patients. The results were statistically analyzed.
RESULTS: Hundred cases of AS were subjected to undergo BMD by Dual Energy X-ray Absorption (DEXA) scan of different age groups in cases 35.19± 8.23(min age 23- max age 67years) and controls 33.27±5.22(min age 22years - max age 44years) with height observed in cases is 169.67±6-87 and controls 170.99±7.16 with weight varied in cases 65.63±10.27 and controls 70.14±10.67.
CONCLUSION: Osteoporosis is a significant complication in ankylosing spondylitis and needs to be monitored and managed at the earliest. Significant osteoporosis can occur even in early disease. Osteoporosis of spine is much more prevalent than femur.BMD spine is still the most important site to define osteoporosis in ankylosing spondylitis. Rise in BMD in LS spine with duration, is not exclusive for subjects with radiologically evident syndesmophytes. Statistically, presence of syndesmophytes did not affect estimation of osteoporosis of spine.

Entities:  

Keywords:  Ankylosing Spondylitis; Bone Mineral Density; Dual Energy x-ray Absorption

Year:  2013        PMID: 24551650      PMCID: PMC3919376          DOI: 10.7860/JCDR/2013/6779.3770

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

1.  Bone mineral density in mild and advanced ankylosing spondylitis.

Authors:  Kazim Capaci; Simin Hepguler; Mehmet Argin; Isil Tas
Journal:  Yonsei Med J       Date:  2003-06-30       Impact factor: 2.759

Review 2.  Bone loss in ankylosing spondylitis: can we put the puzzle together?

Authors:  Daniel Wendling
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

Review 3.  Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset.

Authors:  I Olivieri; C Salvarani; F Cantini; G Ciancio; A Padula
Journal:  Curr Opin Rheumatol       Date:  2001-07       Impact factor: 5.006

Review 4.  Undifferentiated spondyloarthropathies.

Authors:  H Zeidler; W Mau; M A Khan
Journal:  Rheum Dis Clin North Am       Date:  1992-02       Impact factor: 2.670

Review 5.  Rheumatic diseases: the effects of inflammation on bone.

Authors:  Nicole C Walsh; Tania N Crotti; Steven R Goldring; Ellen M Gravallese
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

6.  The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis.

Authors:  Erdal Gilgil; Cahit Kaçar; Tiraje Tuncer; Bülent Bütün
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

Review 7.  Clinical, epidemiologic, and therapeutic aspects of ankylosing spondylitis.

Authors:  J T Gran; G Husby
Journal:  Curr Opin Rheumatol       Date:  1998-07       Impact factor: 5.006

8.  Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases.

Authors:  A B Mullaji; S S Upadhyay; E K Ho
Journal:  J Bone Joint Surg Br       Date:  1994-07

9.  The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.

Authors:  Bedriye Mermerci Başkan; Yasemin Pekin Doğan; Filiz Sivas; Hatice Bodur; Kürşat Ozoran
Journal:  Rheumatol Int       Date:  2009-08-14       Impact factor: 2.631

10.  Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography.

Authors:  J P Devogelaer; B Maldague; J Malghem; C Nagant de Deuxchaisnes
Journal:  Arthritis Rheum       Date:  1992-09
View more
  15 in total

Review 1.  Ankylosing spondylitis: A state of the art factual backbone.

Authors:  Mohammad Ghasemi-Rad; Hosam Attaya; Emal Lesha; Andrea Vegh; Tooraj Maleki-Miandoab; Emad Nosair; Nariman Sepehrvand; Ali Davarian; Hamid Rajebi; Abdolghader Pakniat; Seyed Amirhossein Fazeli; Afshin Mohammadi
Journal:  World J Radiol       Date:  2015-09-28

2.  Clinical outcomes following spinal fracture in patients with ankylosing spondylitis.

Authors:  M Nugent; M J Berney; S Morris
Journal:  Ir J Med Sci       Date:  2017-02-01       Impact factor: 1.568

3.  Ankylosing spondylitis and the risk of cancer.

Authors:  Chih-Cheng Chang; Cheng-Wei Chang; Phung-Anh Alex Nguyen; Tzu-Hao Chang; Ya-Ling Shih; Wen-Ying Chang; Jorng-Tzong Horng; Oscar Kuang-Sheng Lee; Jennifer Hui-Chun Ho
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

4.  Maximum number of bone cross-linked vertebrae: an index for BMD in diffuse idiopathic skeletal hyperostosis.

Authors:  Mitsuru Furukawa; Kunimasa Okuyama; Ken Ninomiya; Yoshiyuki Yato; Takeshi Miyamoto; Masaya Nakamura; Morio Matsumoto
Journal:  J Bone Miner Metab       Date:  2021-11-29       Impact factor: 2.626

Review 5.  The relationship between vitamin D receptor gene polymorphisms and ankylosing spondylitis: a systematic review, meta-analysis and trial sequential analysis.

Authors:  Hang Zhou; Bo-Yang Zhou; Su-Rong Liang; Min Li; Jian Zhao
Journal:  Rheumatol Int       Date:  2022-08-23       Impact factor: 3.580

6.  Monocytes from male patients with ankylosing spondylitis display decreased osteoclastogenesis and decreased RANKL/OPG ratio.

Authors:  V F Caparbo; C G S Saad; J C Moraes; A J de Brum-Fernandes; R M R Pereira
Journal:  Osteoporos Int       Date:  2018-07-13       Impact factor: 4.507

7.  Associations between vitamin D receptor gene polymorphisms and ankylosing spondylitis in Chinese Han population: a case-control study.

Authors:  G Cai; X Zhang; L Xin; L Wang; M Wang; X Yang; X Li; Q Xia; S Xu; C Ding; F Pan
Journal:  Osteoporos Int       Date:  2016-01-27       Impact factor: 4.507

8.  Alendronate Effect on the Prevention of Bone loss in Early Stages of Ankylosing Spondylitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Authors:  Alireza Khabbazi; Hamid Noshad; Sevil Gafarzadeh; Mehrzad Hajialiloo; Susan Kolahi
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

9.  Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis.

Authors:  Inês P Perpétuo; Rita Raposeiro; Joana Caetano-Lopes; Elsa Vieira-Sousa; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

10.  The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases.

Authors:  Yu-Jih Su; Chao Tung Chen; Nai-Wen Tsai; Chih-Cheng Huang; Hung-Chen Wang; Chia-Te Kung; Wei-Che Lin; Ben-Chung Cheng; Chih-Min Su; Sheng-Yuan Hsiao; Cheng-Hsien Lu
Journal:  Am J Mens Health       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.